Hoth Therapeutics, Inc.
HOTH
Revenue
1.24B
▲1.24B∞%
-Assets
10.03M
▲1.54M▲18.15%
3 Months ChangeLiabilities
691.86k
▲33.13k▲5.03%
3 Months ChangeFree Cash Flow
0.00
0.000.00%
-Revenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-11-01
Form 8-K
ID: 0001213900-24-093514
2024-08-09
Form 10-Q
ID: 0001213900-24-067131
2024-08-07
Form 8-K
ID: 0001213900-24-066130
2024-06-17
Form 8-K
ID: 0001213900-24-053359
2024-05-14
Form 10-Q
ID: 0001213900-24-042906
2024-03-28
Form 8-K
ID: 0001213900-24-026868
2024-01-09
Form 8-K
ID: 0001213900-24-002248
2023-11-13
Form 10-Q
ID: 0001213900-23-086133
2023-10-05
Form 8-K
ID: 0001013762-23-002005
2023-09-15
Form 8-K
ID: 0001213900-23-077030